Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 8, 2023
Insight into the mechanism of Xiao-Chai-Hu-Tang alleviates irinotecan-induced diarrhea based on regulating the gut microbiota and inhibiting Gut β-GUSCaiyan Wang, Xiaojun Teng, Chuang Wang, et al.Mabs|September 7, 2020
Engineered Fc-glycosylation switch to eliminate antibody effector functionQun Zhou, Julie Jaworski, Yanfeng Zhou, et al.Journal of Ethnopharmacology|November 12, 2022
Neoline, fuziline, songorine and 10-OH mesaconitine are potential quality markers of Fuzi: In vitro and in vivo explorations as well as pharmacokinetics, efficacy and toxicity evaluationsXiaocui Li, Weiqing Hou, Tingting Lin, et al.Glycobiology|January 26, 2007
Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher diseaseScott M Van Patten, Heather Hughes, Michael R Huff, et al.Bioconjugate Chemistry|January 29, 2013
Site-specific PEGylation of human thyroid stimulating hormone to prolong duration of actionHuawei Qiu, Ekaterina Boudanova, Anna Park, et al.Journal of Molecular Biology|July 12, 2017
Engineering Aglycosylated IgG Variants with Wild-Type or Improved Binding Affinity to Human Fc Gamma RIIA and Fc Gamma RIIIAsTiffany F Chen, Stephen L Sazinsky, Damian Houde, et al.Journal of Virology|December 13, 2019
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological BreadthYu Qiu, Svetlana Stegalkina, Jianxin Zhang, et al.Endocrinology|February 8, 2013
Carbohydrate-mediated polyethylene glycol conjugation of TSH improves its pharmacological propertiesAnna Park, Denise M Honey, Lihui Hou, et al.The Journal of Biological Chemistry|October 30, 2020
A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanismsJames E Stefano, Dana M Lord, Yanfeng Zhou, et al.Journal for Immunotherapy of Cancer|January 2, 2024
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancerKurt A Jenkins, Miso Park, Magali Pederzoli-Ribeil, et al.Pageof 4